登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Cell Host & Microbe，3月23日，Infection and Rapid Transmission of SARS-CoV-2 in Ferrets》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-31

  • Abstract

    The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide. Toprevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV2 is a high priority. We report a ferret model of SARS-CoV-2 infection and transmission thatrecapitulates aspects of human disease. SARS-CoV-2-infected ferrets exhibit elevated bodytemperatures and virus replication. Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine and feces up to 8 days post infection. At 2 days post-contact, SARS-CoV-2 was detected in all naïve direct contactferrets. Furthermore, a few naïve indirect contact ferrets were positive for viral RNA,suggesting airborne transmission.

  • 原文来源：https://els-jbs-prod-cdn.jbs.elsevierhealth.com/pb-assets/journals/research/cell-host-microbe/PDFs/chom_2285_preproof-1585580136920.pdf
92浏览量
原文链接
相关报告

  • 《LANCET，3月23日，SARS-CoV-2: virus dynamics and host response》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-24
    • SARS-CoV-2: virus dynamics and host response Yu Chen Lanjuan Li Published:March 23, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30235-8 Since December, 2019, coronavirus disease 2019 (COVID-19) has affected more than 100?000 patients globally.1 COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 2·3%, with higher rates among elderly patients and patients with comorbidities.2 Person-to-person transmission is efficient, with multiple clusters reported. Clinically, patients with COVID-19 present with respiratory symptoms, which is very similar to the presentation of other respiratory virus infections.
    137浏览量
    原文链接

  • 《Cell Host & Microbe，6月19日，Neutralisation of SARS-CoV-2 by destruction of the prefusion Spike》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-06-20
    • Neutralisation of SARS-CoV-2 by destruction of the prefusion Spike JiandongHuo123∗YuguangZhao1∗JingshanRen1DamingZhou1Helen ME.Duyvesteyn1Helen M.Ginn6LoicCarrique1TomasMalinauskas1Reinis R.Ruza1Pranav NM.Shah1Tiong KitTan4PramilaRijal4NaomiCoombes5Kevin R.Bewley5Julia A.Tree5JulikaRadecke6Neil G.Paterson6PiyasaSupasa7…David I.Stuart169$ https://doi.org/10.1016/j.chom.2020.06.010 Summary There are as yet no licenced therapeutics for the COVID-19 pandemic. The causal coronavirus (SARS-CoV-2) binds host cells via a trimeric Spike whose receptor binding domain (RBD) recognises angiotensin-converting enzyme 2 (ACE2), initiating conformational changes that drive membrane fusion. We find that the monoclonal antibody CR3022 binds the RBD tightly, neutralising SARS-CoV-2 and report the crystal structure at 2.4 Å of the Fab/RBD complex. Some crystals are suitable for screening for entry-blocking inhibitors. The highly conserved, structure-stabilising, CR3022 epitope is inaccessible in the prefusion Spike, suggesting that CR3022 binding facilitates conversion to the fusion-incompetent post-fusion state. Cryo-EM analysis confirms that incubation of Spike with CR3022 Fab leads to destruction of the prefusion trimer. Presentation of this cryptic epitope in an RBD-based vaccine might advantageously focus immune responses. Binders at this epitope may be useful therapeutically, possibly in synergy with an antibody blocking receptor attachment.
    29浏览量
    原文链接